ILEX Oncology was acquired by Genzyme on December 21, 2004

Life Science Company

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2004. The largest life science acquisition in 2004 was Sicor - which was acquired by Teva Pharmaceutical Industries for $3.4B.

Join Mergr to view all 51 acquisitions of life science companies in 2004, including 11 acquisitions by private equity firms, and 40 by strategics.

ILEX Oncology, Inc.

4545 Horizon Hill Boulevard,
San Antonio, Texas 78229
United States,
(210) 949-8200

ILEX Oncology, Inc. is a drug development company focused exclusively on the accelerated development of drugs for the treatment and prevention of cancer. ILEX Oncology was founded in 1992 and is based in San Antonio, Texas.


 Subscribe to unlock this and 164,024
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 153K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.